ATLANTA — Health experts are emphasizing the importance of human papillomavirus vaccination as a key strategy for preventing cervical cancer, encouraging families to review vaccination records and ensure that eligible children and young adults receive recommended protection.
Human papillomavirus, commonly known as HPV, is a widespread group of viruses. Most infections clear on their own, but persistent infection with certain high-risk types can cause changes in cells that may eventually develop into cancer. HPV is responsible for nearly all cases of cervical cancer and is also associated with several other cancers.
Vaccination helps prevent infection from HPV types responsible for a large proportion of cervical cancer cases. The vaccine works best when administered before a person is exposed to the virus, which is why routine vaccination is recommended during the preteen years.
In the United States, the CDC routinely recommends HPV vaccination at ages 11 or 12, although vaccination can begin at age 9. Catch-up vaccination is recommended for people who were not adequately vaccinated earlier, with recommendations depending on age and individual circumstances.
The number of doses required depends on the age when vaccination begins and whether a person has certain immune conditions. Parents and patients should consult current CDC guidance or a healthcare professional to determine the appropriate schedule.
One of the most important benefits of HPV vaccination is cancer prevention. By reducing infection with high-risk HPV types, vaccination can lower the risk of developing cervical precancers and cancers associated with the virus. It can also help prevent other HPV-related cancers, including some cancers of the throat and genital region.
Despite its benefits, HPV vaccination coverage varies among communities. Concerns about vaccine safety, limited access to healthcare, missed appointments and inconsistent recommendations can contribute to gaps in protection.
Healthcare professionals can help address these barriers by discussing vaccination during routine visits and explaining that the vaccine is intended to prevent future infections, rather than treat an existing infection. Parents may also find it helpful to ask clinicians about expected side effects, which are generally mild and temporary, such as soreness at the injection site.
Vaccination does not eliminate the need for cervical cancer screening. Screening can detect abnormal cervical cell changes and identify cancer at an earlier stage. Recommended screening schedules depend on age, medical history and current clinical guidance.
The combination of vaccination and appropriate screening offers a strong approach to reducing cervical cancer risk. However, access to preventive care remains uneven, particularly for people who lack regular healthcare providers or face financial and transportation barriers.
Public health campaigns often focus on explaining the benefits of vaccination in clear, age-appropriate language. Healthcare professionals also encourage parents to treat HPV vaccination as part of routine adolescent immunization rather than a decision that needs to be delayed until adulthood.
For people who missed vaccination during adolescence, catch-up options may still be available. Adults should discuss their individual circumstances with a healthcare professional because recommendations vary by age and prior vaccination status.
Cervical cancer remains a preventable public health challenge, but prevention requires consistent action. Improving vaccination coverage, maintaining screening access and ensuring that patients receive accurate information can help reduce future disease burden.
The message from health experts is straightforward: HPV vaccination is an established preventive measure, and timely vaccination combined with appropriate screening can help protect individuals from cervical cancer and other HPV-related diseases.

